Market Tracker

01/24 12:13pm ET

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

41.40
BATS BZX Real-Time Price
As of 12:13pm ET
 -2.54 / -5.78%
Today’s Change
19.59
Today|||52-Week Range
57.00
-13.44%
Year-to-Date
Biogen's Multiple Sclerosis Franchise to Drive Growth in 2017
Jan 17 / Zacks.com - Paid Partner Content
Company News for January 11, 2017
Jan 11 / Zacks.com - Paid Partner Content
Is Biogen's Stock Ready to Heat Up After a Forgettable 2016?
Jan 13 / MotleyFool.com - Paid Partner Content
The 1 Biotech Stock I Want to Own in 2017
Jan 11 / MotleyFool.com - Paid Partner Content
Why Ionis Pharmaceuticals Shares Fell by 22.8% in 2016
Jan 12 / MotleyFool.com - Paid Partner Content
3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock
Jan 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close43.94
Today’s open43.70
Day’s range41.09 - 43.80
Volume62,023
Average volume (3 months)2,285,669
Market cap$5.3B
Dividend yield--
Data as of 12:13pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-41.22%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book26.34

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.32-2.29%
UTHRUnited Therapeutics ...+2.01+1.31%
MNKMallinckrodt Plc+0.43+0.94%
OPKOPKO Health Inc-0.03-0.35%
Data as of 12:13pm ET, 01/24/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts